Ac­tivist in­vestor wages suit on On­coSec over re­cent deal; Breast can­cer ex­perts de­but biotech with $12M seed

→ Hav­ing raised is­sues with On­coSec’s re­cent deal giv­ing Chi­na Grand Phar­ma­ceu­ti­cal a con­trol­ling stake in the mi­cro­cap biotech, ac­tivist share­hold­er Al­pha Hold­ings is wag­ing a full-on class ac­tion com­plaint against the drug­mak­er. In its briefs, South Ko­rea-based Al­pha Hold­ings is ac­cus­ing On­coSec ex­ecs of sell­ing con­trol of the com­pa­ny on the cheap. On­coSec has filed a mo­tion to dis­miss the suit, and a hear­ing will take place ear­ly next week.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER